Increased assessment of HER2 in metastatic gastroesophageal cancer patients: a nationwide population-based cohort study

BACKGROUND: Addition of trastuzumab to first-line palliative chemotherapy in gastroesophageal cancer patients with HER2 overexpression has shown to improve survival. Real-world data on HER2 assessment and administration of trastuzumab are lacking. The aim of this study was to assess HER2 testing, tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Dijksterhuis, Willemieke P. M., Verhoeven, Rob H. A., Meijer, Sybren L., Slingerland, Marije, Haj Mohammad, Nadia, de Vos-Geelen, Judith, Beerepoot, Laurens V., van Voorthuizen, Theo, Creemers, Geert-Jan, van Oijen, Martijn G. H., van Laarhoven, Hanneke W. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305095/
https://www.ncbi.nlm.nih.gov/pubmed/31927675
http://dx.doi.org/10.1007/s10120-020-01039-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305095/
https://www.ncbi.nlm.nih.gov/pubmed/31927675
http://dx.doi.org/10.1007/s10120-020-01039-7

Ejemplares similares